<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reversible cerebral vasoconstriction syndrome is a rare cause of <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> in the pediatric population </plain></SENT>
<SENT sid="1" pm="."><plain>Reversible vasoconstriction is reported in a 19-month-old girl with <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> who underwent selective ophthalmic artery infusion chemotherapy with melphalan </plain></SENT>
<SENT sid="2" pm="."><plain>Procedure-related cerebral vasoconstriction was specifically triggered during coadministration of adjunctive medications, which included mydriatic eye drops containing <z:chebi fb="0" ids="8093">phenylephrine</z:chebi>, intranasal oxymetazoline, nebulized <z:chebi fb="0" ids="2549">albuterol</z:chebi>, intravenous <z:chebi fb="2" ids="17650">hydrocortisone</z:chebi>, and intravenous diphenhydramine </plain></SENT>
<SENT sid="3" pm="."><plain>The course of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, which began with a severe hypertensive surge and resolved spontaneously within hours of blood pressure normalization, was documented by angiography in real time </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequent brain magnetic resonance imaging showed no evidence of perfusion abnormality, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, or <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo>, and the patient was discharged home without any neurologic sequelae </plain></SENT>
<SENT sid="5" pm="."><plain>In this report, we highlight the potential risk of reversible cerebral vasoconstriction in children administered vasoactive drugs and discuss its relevance during treatment of <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> by intraarterial chemotherapy </plain></SENT>
</text></document>